<?xml version="1.0"?>
<Articles JournalTitle="Immunology and Genetics Journal">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>3</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>09</Month>
        <Day>22</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Normal Expression of Cytotoxic T-lymphocyte- As-sociated Protein4 (CTLA4) in a Lipopolysaccharide-Responsive and Beige-like Anchor Protein (LRBA)Deficient Patient</title>
    <FirstPage>53</FirstPage>
    <LastPage>58</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Fereshte</FirstName>
        <LastName>Salami</LastName>
        <affiliation locale="en_US">Reproductive Immuology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>07</Month>
        <Day>13</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Bialelic LRBA mutations leads to an Immune dysregulation disorder which name is LRBA deficiency. A wide spectrum of clinical manifestation associated with recurrent infections, enteropathy, hypogammaglobulinemia, and autoimmune manifestations. LRBA interacts with CTLA-4 within recycling it to the T-cell surface. Accordingly, LRBA deficiency abolish CTLA4 protein expression. In this study, we present a case with homozygous mutation in LRBA gene and normal level of CTLA4 protein. This patient revelaed low immunoglobulin levels, CD4+ cells, and CD19+ cells.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/57</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/57/48</pdf_url>
  </Article>
</Articles>
